Notice2022-09949
Advisory Council for the Elimination of Tuberculosis
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
May 10, 2022
Issuing agencies
Health and Human Services DepartmentCenters for Disease Control and Prevention
Abstract
In accordance with the Federal Advisory Committee Act, the CDC announces the following meeting of the Advisory Council for the Elimination of Tuberculosis (ACET). This meeting is open to the public and limited to 1,000 audio and web conference lines. Members of the public are welcome to listen to the meeting by accessing the telephone number and web access provided in the addresses section below. Time will be available for public comment (registration required to provide oral comment).
Full Text
<html>
<head>
<title>Federal Register, Volume 87 Issue 90 (Tuesday, May 10, 2022)</title>
</head>
<body><pre>
[Federal Register Volume 87, Number 90 (Tuesday, May 10, 2022)]
[Notices]
[Pages 28012-28013]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2022-09949]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Advisory Council for the Elimination of Tuberculosis
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice of meeting.
-----------------------------------------------------------------------
SUMMARY: In accordance with the Federal Advisory Committee Act, the CDC
announces the following meeting of the Advisory Council for the
Elimination of Tuberculosis (ACET). This meeting is open to the public
and limited to 1,000 audio and web conference lines. Members of the
public are welcome to listen to the meeting by accessing the telephone
number and web access provided in the addresses section below. Time
will be available for public comment (registration required to provide
oral comment).
DATES: The meeting will be held on June 21, 2022, from 10:00 a.m. to
4:30 p.m., EDT, and June 22, 2022, from 10:00 a.m. to 12:05 p.m., EDT.
Written comments must be received on or before June 7, 2022.
Registration to make oral comments must be submitted by June 16, 2022.
ADDRESSES: The telephone access number is 1-669-254-5252, Webinar ID:
160 137 0413, and the Passcode is 37403108. The web conference access
is <a href="https://cdc.zoomgov.com/j/1601370413?pwd=T0pucU1yNENQVUlRNUNVUVBKbHh2UT09">https://cdc.zoomgov.com/j/1601370413?pwd=T0pucU1yNENQVUlRNUNVUVBKbHh2UT09</a>, and the Passcode is
[caret]Sm35?s2. The number of available audio and web conference lines
is 1,000.
FOR FURTHER INFORMATION CONTACT: Marah Condit, MS, Committee Management
Lead, National Center for HIV, Viral Hepatitis, STD, and TB Prevention,
CDC, 1600 Clifton Road NE, Mailstop US8-6, Atlanta, GA 30329-4027,
Telephone:(404)639-3423; Email: <a href="/cdn-cgi/l/email-protection#78161b10100b0c08081714111b01381b1c1b561f170e"><span class="__cf_email__" data-cfemail="b4dad7dcdcc7c0c4c4dbd8ddd7cdf4d7d0d79ad3dbc2">[email protected]</span></a>.
SUPPLEMENTARY INFORMATION:
Purpose: The Council advises and makes recommendations to the
Secretary of Health and Human Services, the Assistant Secretary for
Health, and the Director, CDC, regarding the elimination of
tuberculosis. Specifically, the Council makes recommendations regarding
policies, strategies, objectives, and priorities; addresses the
development and application of new technologies; and reviews the extent
to which progress has been made toward eliminating tuberculosis.
[[Page 28013]]
Matters to be Considered: The agenda will include discussions on
(1) NIH-funded clinical trials; (2) domestic pediatric tuberculosis;
(3) immigration and tuberculosis; and (4) considerations for bringing
new tuberculosis drugs to market. Agenda items are subject to change as
priorities dictate.
Public Participation
Written Public Comment: Members of the public are welcome to submit
written comments in advance of the meeting. Written comments must be
submitted by emailing <a href="/cdn-cgi/l/email-protection#aec0cdc6c6dddadedec1c2c7cdd7eecdcacd80c9c1d8"><span class="__cf_email__" data-cfemail="016f626969727571716e6d686278416265622f666e77">[email protected]</span></a> with subject line ``June
ACET Public Comment Registration'' by June 7, 2022.
Oral Public Comment: Individuals who would like to make an oral
comment during the public comment period must register by emailing
<a href="/cdn-cgi/l/email-protection#f39d909b9b808783839c9f9a908ab3909790dd949c85"><span class="__cf_email__" data-cfemail="7c121f14140f080c0c1310151f053c1f181f521b130a">[email protected]</span></a> with subject line ``June ACET Public Comment
Registration'' by June 16, 2022. The public comment period is on June
22, 2022, at 11:55 a.m., EDT.
The Director, Strategic Business Initiatives Unit, Office of the
Chief Operating Officer, Centers for Disease Control and Prevention,
has been delegated the authority to sign Federal Register notices
pertaining to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention and
the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2022-09949 Filed 5-9-22; 8:45 am]
BILLING CODE 4163-18-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on May 10, 2022.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.